Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1 - Communications Medicine Fernandez et al. compare the HTLV-1 proviral load in people with HIV-1-HTLV-1 coinfection on stable antiretroviral therapy or people with HTLV-1 single infection without antiretroviral therapy. Dolutegravir use for longer than six months is associated with lower HTLV-1 proviral load.

🚨 NEW RESEARCH! ⚕️ 🩺


Fernandez et al. assess Dolutegravir use and HTLV-1 proviral load in HIV-HTLV-1 coinfected patients.

http://dlvr.it/TRJkWj #AntiretroviralTherapy #HTLV1

Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy An official website of the United States government

Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy #HTLV1 #MECFS #LongCovid

pmc.ncbi.nlm.nih.gov/articles/PMC...

【ブログ更新】
白血病発症リスクとHTLV-1ウイルス：UMKテレビ宮崎が伝える、研究最前線の希望

#HTLV1 #白血病 #医療研究 #健康情報 kenko-mosunon.blogspot.com/2025/11/htlv-1umk.html

WHO to Develop First Global Guidelines on Human T-Cell Lymphotropic Virus-1 (HTLV-1) Prevention and Testing - WHO will draft its first global guidelines on Human T-cell lymphotropic virus-1 (HTLV-1) testing and prevention, marking a critical s

WHO to Develop First Global Guidelines on Human T-Cell Lymphotropic Virus-1 (HTLV-1) Prevention and Testing wiobs.com/who-to-devel... #WHO #HTLV1 #PublicHealth #GlobalHealth #ViralDiseases

NewsMatch Alert: Press Release Summary | 22 July 2025 Welcome to Medianet’s daily media alert featuring a curated list of today's most newsworthy press releases handpicked by our editorial team. Today's highlights Women and girls at centre of worsening h...

🔢 Today's Press Release Highlights from Medianet 🔢
www.linkedin.com/pulse/newsma...

#Homelessness #HousingCrisis #GazaVigil #HTLV1 #WomensGiving #SheGives #Philanthropy #AustraliaNews #pressrelease #pressreleasedistribution #australia #australianews #media #journalists